Reducing complications and treatment of patients with polycystic ovary syndrome
- Conditions
- polycystic ovarian syndrome: PCOS.Sclerocystic ovary syndrome-Stein-Leventhal syndrome
- Registration Number
- IRCT2016041227353N1
- Lead Sponsor
- Vice chancellor for research, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion criteria for patients: Diagnosis of PCOS according to the Rotterdam criteria, aged between 25 and 35 years, the lack of Oral contraceptive pill (OCP) and hormone analogues Apart from progesterone , The use of assisted reproductive medicine at the same dose in all cases, the absence of other systemic diseases known, the first IVF cycle in patients.
exclusion criteria for patients : Hyperprolactinemia, thyroid disease, congenital adrenal hyperplasia, testosterone-secreting tumors, Cushing, endometriosis, FSH above 10 IU / L on the third day after menstrual bleeding,
Use of drugs that affect the metabolism of carbohydrates, using an analog of the hormone progesterone than three months before entering the study and severe kidney and liver diseases.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Apoptosis. Timepoint: 6 weeks after intervention. Method of measurement: Real Time PCR.
- Secondary Outcome Measures
Name Time Method